XML 38 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Tables)
6 Months Ended
Mar. 31, 2024
Share-based Compensation  
Schedule of stock-based compensation expense

Three months ended March 31, 

Six months ended March 31, 

2024

    

2023

    

2024

    

2023

Research and development

$

236,960

$

322,268

$

468,376

$

612,924

General and administrative

1,073,547

1,061,137

2,114,742

2,162,874

$

1,310,507

$

1,383,405

$

2,583,118

$

2,775,798

Schedule of performance-based stock units activity

Weighted

Average

Number

Exercise

Remaining

of

Price

Contractual

Aggregate

    

PSUs

    

Per PSU

    

Term (Years)

    

Intrinsic Value

Balance at October 1, 2023

123

$

999.40

Forfeitures

Balance at March 31, 2024

123

$

999.40

0.3

$

Exercisable at March 31, 2024

123

$

999.40

0.3

$

Vested and expected to vest at March 31, 2024

123

$

999.40

0.3

$

Employee Stock Option [Member]  
Share-based Compensation  
Schedule of stock option activity

Weighted

Average

Weighted

Remaining

Number of

Average

Contractual

Aggregate

    

Shares

    

Exercise Price

    

Term (Years)

    

Intrinsic Value

Balance at October 1, 2023

1,197,774

$

28.72

Granted

799,729

6.70

Forfeited

(29,605)

27.93

Expired

(8,333)

33.60

Balance at March 31, 2024

1,959,565

$

19.72

8.2

$

4,219,550

Exercisable at March 31, 2024

875,865

$

27.62

7.0

$

383,313

Vested and expected to vest at March 31, 2024

1,959,565

$

19.72

8.2

$

4,219,550

Schedule of option assumptions

Six months ended March 31, 

2024

    

2023

Risk-free interest rate

    

4.3

%  

3.7

%

Expected term (years)

6.0

5.7

Expected volatility

131.3

%  

112.4

%

Expected dividend yield

Performance-based stock options  
Share-based Compensation  
Schedule of stock option activity

Weighted

Average

Weighted

Remaining

Number of

Average

Contractual

Aggregate

    

Shares

    

Exercise Price

    

Term (Years)

    

Intrinsic Value

Balance at October 1, 2023

35,000

$

28.80

Granted

634,000

6.78

Balance at March 31, 2024

669,000

$

7.93

9.9

$

3,271,440

Exercisable at March 31, 2024

35,000

$

28.80

7.7

$

Vested and expected to vest at March 31, 2024

669,000

$

7.93

9.9

$

3,271,440

Schedule of option assumptions

Six months ended March 31, 

    

2024

    

2023

Risk-free interest rate

4.3

%  

3.8

%

Expected term (years)

10.0

10.0

Expected volatility

125.6

%  

91.3

%

Expected dividend yield